GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
Welcome to the Science Lab session hosted by Karin Jacobson from JTI Geneva. In this presentation, Anna Masser from Swedish Match discusses nicotine content and nicotine uptake in cigarettes and nicotine pouches, comparing their delivery methods, uptake rates, and how they are used both in clinical settings and real life.
The video covers: - Differences between nicotine delivery in cigarettes vs. nicotine pouches - Standardized clinical testing protocols for nicotine uptake - Pharmacokinetic profiles and plasma nicotine concentration over time - Real-world use comparison of nicotine pouches and cigarettes - Insights into nicotine metabolism and cotinine levels - Discussion on regulated nicotine limits and product risk profiles - Audience Q&A addressing nicotine kinetics and product comparisons
📅 7 Oct 2025
GFN News #159 | VAPING ER “SURGE”: What The Data Really Shows?
GFN News speaks with Filter’s Will Godfrey about reports of dramatic increases in vaping-related emergency department visits across several US states, especially among youth, and examines what those numbers truly represent beyond the headlines. The conversation highlights how headlines like “teen ER visits surge” can obscure distinctions between acute nicotine toxicity and far more subjective “e‑cigarette dependence” admissions that have driven much of the increase in reported cases. The discussion also explores how clinicians may mark visits as vape-related simply because a patient discloses vaping, even when it’s incidental to the medical issue, potentially inflating counts without reflecting actual vaping-caused harm.
Toxicologist Autumn Bernal explains why harm reduction keeps her in the fight: reducing disease burden for adult smokers through better product design, rigorous toxicology, and clear science communication. She highlights the core engineering challenge for ENDS: optimizing heating to minimize emissions while effectively delivering nicotine - without the harmful constituents found in cigarettes.
📅 1 Oct 2025
GFN Voices 2025 #13 | HOW TO CUT TOBACCO HARM IN LMICs?
Challenging misconceptions can save lives. Too often, outdated beliefs and misinformation prevent people from accessing safer alternatives to cigarettes. Today, Dr. Sud Patwardhan sheds light on how evidence-based strategies can help cut tobacco-related harm, especially in low- and middle-income countries where the burden of smoking is highest.
📅 29 Sep 2025
GFN25 Commentary Team #4 | Australia’s Vape Prohibition Backfire | Hosted by Fiona Patten
Australia’s vape prohibition is fueling a booming illicit market—while New Zealand’s regulated approach sees smoking rates fall faster. In this GFN 2025 conversation, Fiona Patten speaks with Rohan Pike and Asa Saligupta about what’s broken in tobacco control, what actually works in harm reduction.
GFN.TV Interviews #73 | EMOTIONAL OVERRIDE | Why Feelings, Not Facts, Distort the Risk of Safer Nicotine
Public health’s assault on vaping and safer nicotine products isn’t guided by evidence, it’s driven by fear, outrage, and a profound misunderstanding of risk. At GFN 2025 in Warsaw, David Zaruk, the “Risk-Monger,” reveals how emotion overrides science in policymaking. From the misuse of the Precautionary Principle to the denormalization of entire industries, Zaruk argues that activist zeal and WHO dogma have turned nicotine into a moral battleground, sacrificing harm reduction and leaving millions of smokers without safer options.
Featuring:
DAVID ZARUK Environmental-Health Risk Analyst Author, The Risk-Monger @zaruk risk-monger.com
📅 24 Sep 2025
GFN Voices 2025 #12 | BRAZIL's EFFORT FOR SAFER NICOTINE | Alexandro Lucian on Translating Science in LATAM
Explore tobacco harm reduction at GFN through a candid interview with Brazilian consumer advocate Alexandro Lucian, who shares why this global event matters, the misinformation challenges in Brazil, and why education and accurate science are essential for safer nicotine choices. Learn how language barriers, anti‑vaping narratives, and limited local research shape public opinion—and how translating complex evidence into Portuguese helps counter myths.
📅 22 Sep 2025
GFN Voices 2025 #11 | BREAKING THE NOISE | How Consumers Fight Vaping Misinformation in New Zealand?
In this interview, tobacco harm reduction advocate Nancy Loucas unpacks how consumer voices are pushing back against vaping misinformation in New Zealand, why education matters in a “post-truth” world, and how Asia-Pacific communities win by doing it “their way".
📅 19 Sep 2025
GFN.TV Interviews #72 | OPTIONS MATTER | Lisbon’s Vaping Project for Marginalized Groups
Portugal is celebrated for its progressive drug policy, yet tobacco harm reduction remains sidelined. At GFN 2025 in Warsaw, Adriana Curado of GAT in Lisbon shows how nicotine became “the forgotten substance.” From her own move away from smoking to a pioneering vaping project with people who use drugs and those experiencing homelessness, Curado exposes public health contradictions, the persistence of stigma, and why safer nicotine options matter—especially for marginalized groups.
Featuring: ADRIANA CURADO Harm Reduction Expert, Community Research Officer Grupo de Ativistas em Tratamentos (GAT) @curadoadriana
📅 17 Sep 2025
GFN Voices 2025 #10 | Armenia’s THR Challenge | Satenik Muradyan on Fighting Misinformation and Youth Perception
Armenian doctor Satenik Muradyan explains why education is key to tobacco harm reduction, revealing that over 80% of physicians in Armenia lack smoking-cessation training, how misconceptions about tar vs. nicotine fuel resistance, divided youth attitudes toward safer nicotine products, and why step-by-step, evidence-based communication works - insights shared at GFN on overcoming deeply rooted misinformation.
